Cancer antigens

Industry

CPC
A61K39/0011

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

AHUMAN NECESSITIES A61Medical science A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES A61K39/00Medicinal preparations containing antigens or antibodies

Current Industry

A61K39/0011Cancer antigens

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,168,043
- Issue date Dec 17, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,168,044
- Issue date Dec 17, 2024
- Immatics Biotechnologies GmbH
- Toni Weinschenk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibody against glypican-3 and application thereof
- Patent number 12,168,061
- Issue date Dec 17, 2024
- CRAGE MEDICAL CO., LIMITED
- Huamao Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cell receptor-deficient t cell compositions
- Patent number 12,168,780
- Issue date Dec 17, 2024
- Trustees of Dartmouth College
- Charles L. Sentman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bacillus Calmette-Guerin (BCG) and antigen presenting cells for tre...
- Patent number 12,168,048
- Issue date Dec 17, 2024
- NantCell, Inc.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cancer using disulfide-linked trimeric OX40L
- Patent number 12,168,686
- Issue date Dec 17, 2024
- Sichuan Clover Biopharmaceuticals, Inc
- Peng Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tissue factor pathway inhibitor antibodies and uses thereof
- Patent number 12,168,698
- Issue date Dec 17, 2024
- Pfizer Inc.
- Debra Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccine in combination with an immune checkpoint inhibitor for use...
- Patent number 12,168,045
- Issue date Dec 17, 2024
- Ultimovacs ASA
- Gustav Gaudernack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-MERTK agonistic antibodies and uses thereof
- Patent number 12,162,942
- Issue date Dec 10, 2024
- The Rockefeller University
- Sohail F. Tavazoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and vaccines for use in treating ROR1 cancers and inhibi...
- Patent number 12,162,950
- Issue date Dec 10, 2024
- The Regents of the University of California
- Thomas James Kipps
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptor specific for tumor cells
- Patent number 12,161,705
- Issue date Dec 10, 2024
- MILTENYI BIOTEC B.V. & CO. KG
- Dominik Eckardt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions targeting apoptosis-associated speck-like protein with...
- Patent number 12,162,916
- Issue date Dec 10, 2024
- UNM Rainforest Innovations
- Bryce Chackerian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immune tolerant elastin-like peptide tetramer guided nanoparticles...
- Patent number 12,162,923
- Issue date Dec 10, 2024
- Univeristy of Utah Research Foundation
- Mingnan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EPHA2 antibodies
- Patent number 12,162,945
- Issue date Dec 10, 2024
- Immunome, Inc.
- Alexander Scholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer vaccines targeting BORIS and uses thereof
- Patent number 12,161,706
- Issue date Dec 10, 2024
- Inovio Pharmaceuticals, Inc.
- Jian Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
B*44 restricted peptides for use in immunotherapy against cancers a...
- Patent number 12,162,917
- Issue date Dec 10, 2024
- Immatics Biotechnologies GmbH
- Colette Song
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhanced antigen presenting ability of RNA car T cells by co-introd...
- Patent number 12,162,922
- Issue date Dec 10, 2024
- Novartis AG
- Yangbing Zhao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CaMKK2 inhibitor compositions and methods of using the same
- Patent number 12,158,399
- Issue date Dec 3, 2024
- Duke University
- Luigi Racioppi
- G01 - MEASURING TESTING
Information Patent Grant
CCR8 peptide and T cells for use in immunotherapeutic treatment of...
- Patent number 12,156,905
- Issue date Dec 3, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides and combination of peptides and scaffolds thereof for use...
- Patent number 12,150,979
- Issue date Nov 26, 2024
- Immatics Biotechnologies GmbH
- Oliver Schoor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Concatemeric peptide epitope RNAs
- Patent number 12,150,980
- Issue date Nov 26, 2024
- ModernaTX, Inc.
- Giuseppe Ciaramella
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors targeting CD70
- Patent number 12,152,081
- Issue date Nov 26, 2024
- Pfizer Inc.
- Surabhi Srivatsa Srinivasan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic dinucleotide analogue, pharmaceutical composition thereof, a...
- Patent number 12,152,051
- Issue date Nov 26, 2024
- SHANGHAI DE NOVO PHARMATECH CO., LTD.
- Zhaolong Tong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for car T cell therapy
- Patent number 12,144,850
- Issue date Nov 19, 2024
- Purdue Research Foundation
- Philip Stewart Low
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cell modification and use thereof
- Patent number 12,145,990
- Issue date Nov 19, 2024
- ADAPTIMMUNE LIMITED
- Garth Hamilton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccinal strategy
- Patent number 12,144,851
- Issue date Nov 19, 2024
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- François Lang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,144,852
- Issue date Nov 19, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds including a mutant KRAS sequence and a lipid and uses the...
- Patent number 12,138,301
- Issue date Nov 12, 2024
- Elicio Therapeutics, Inc.
- Peter C. Demuth
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleoside-modified RNA for inducing an adaptive immune response
- Patent number 12,138,305
- Issue date Nov 12, 2024
- The Trustees of the University of Pennsylvania
- Drew Weissman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...
- Patent number 12,139,538
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSC...
- Publication number 20240418731
- Publication date Dec 19, 2024
- Genentech, Inc.
- Lelia DELAMARRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC RNA FOR LUNG CANCER
- Publication number 20240415946
- Publication date Dec 19, 2024
- BIONTECH SE
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAIN...
- Publication number 20240408166
- Publication date Dec 12, 2024
- Immatics Biotechnologies GmbH
- Toni WEINSCHENK
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES
- Publication number 20240409608
- Publication date Dec 12, 2024
- NAVICURE BIOPHARMACEUTICALS LIMITED
- Chia-Mao WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER
- Publication number 20240408197
- Publication date Dec 12, 2024
- Memorial Sloan-Kettering Cancer Center
- David A. SCHEINBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EMBRYONIC ANGIOGENESIS MARKERS AND DIAGNOSTIC AND THERAPEUTIC STRAT...
- Publication number 20240409595
- Publication date Dec 12, 2024
- Stichting Amsterdam UMC
- Arjan Willem GRIFFIOEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER
- Publication number 20240398917
- Publication date Dec 5, 2024
- Cancer Advances Inc.
- Lynda Sutton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VERSATILE VIRUS-LIKE-VESICLES (VLV) PLATFORM FOR INFECTIOUS DISEASE...
- Publication number 20240398921
- Publication date Dec 5, 2024
- Carogen Corporation
- Valerian Nakaar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPO...
- Publication number 20240400713
- Publication date Dec 5, 2024
- Memorial Sloan-Kettering Cancer Center
- Maria Themeli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCED CELL-DERIVED VESICLES FOR CANCER THERAPY
- Publication number 20240398861
- Publication date Dec 5, 2024
- Research Institute at Nationwide Children's Hospital
- Kevin A. Cassady
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION
- Publication number 20240398864
- Publication date Dec 5, 2024
- MIE UNIVERSITY
- Fumiyasu MOMOSE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF
- Publication number 20240398865
- Publication date Dec 5, 2024
- THE BROAD INSTITUTE, INC.
- Edward Fritsch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRIMERIC ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS A...
- Publication number 20240398920
- Publication date Dec 5, 2024
- CytomX Therapeutics, Inc.
- Erwan LE SCOLAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240400632
- Publication date Dec 5, 2024
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DESIGN OF IMMUNOSTIMULATORY PROTEIN-CORE SPHERICAL NUCLEIC ACIDS
- Publication number 20240398918
- Publication date Dec 5, 2024
- Northwestern University
- Chad A. Mirkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EPITOPE PEPTIDE FOR TUMOR-ASSOCIATED ANTIGEN AND USE THEREOF
- Publication number 20240398919
- Publication date Dec 5, 2024
- SHENZHEN INSTITUTES OF ADVANCEDTECHNOLOGY CHINESE ACADEMY OF SCIENCES
- Jiandong HUANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VECTOR FOR CANCER TREATMENT
- Publication number 20240401075
- Publication date Dec 5, 2024
- CANCER RESEARCH TECHNOLOGY LIMITED
- Lian Ni LEE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
- Publication number 20240392038
- Publication date Nov 28, 2024
- Minerva Biotechnologies Corporation
- Cynthia Bamdad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY
- Publication number 20240390468
- Publication date Nov 28, 2024
- IMMUNOVACCINE TECHNOLOGIES INC.
- Valerie PICARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TLR AGONISTS FOR REDUCING ACTIVATION-INDUCED PD-1 EXPRESSION ON T C...
- Publication number 20240390487
- Publication date Nov 28, 2024
- Wisconsin Alumni Research Foundation
- Douglas G. McNeel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINATION IN ELDERLY PATIENTS
- Publication number 20240390478
- Publication date Nov 28, 2024
- CureVac SE
- Karl-Josef KALLEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
- Publication number 20240392011
- Publication date Nov 28, 2024
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA CONSTRUCTS AND USES THEREOF
- Publication number 20240390524
- Publication date Nov 28, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Application
TRANSGENIC MOUSE EXPRESSING HUMAN CEREBLON
- Publication number 20240389562
- Publication date Nov 28, 2024
- Celgene Corporation
- Rajesh Chopra
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
- Publication number 20240382572
- Publication date Nov 21, 2024
- COGNATE BIOSERVICES, INC.
- Marnix Leo Bosch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF COMPACT PEPTIDE VACCINES USING RESIDUE OPTIMIZATION
- Publication number 20240383963
- Publication date Nov 21, 2024
- Think Therapeutics, Inc.
- David Kenneth GIFFORD
- G01 - MEASURING TESTING
Information Patent Application
POLYMERIC NANOPARTICLE GENETIC VACCINES
- Publication number 20240382429
- Publication date Nov 21, 2024
- The Johns Hopkins University
- Jordan J. GREEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NANOPARTICLES FOR ANTIGEN-SPECIFIC CELL PROGRAMMING AND USES THEREOF
- Publication number 20240382606
- Publication date Nov 21, 2024
- Georgia Tech Research Corporation
- Gabriel A. Kwong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFEREN...
- Publication number 20240374640
- Publication date Nov 14, 2024
- Immatics Biotechnologies GmbH
- Ricarda HANNEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIPLEXED TP53 AND PAN-RAS mRNA CANCER VACCINES
- Publication number 20240374697
- Publication date Nov 14, 2024
- RNAimmune, Inc.
- Dong SHEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Cancer antigens

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Peptides and combination of peptides for use in immunotherapy again...

Peptides and combination of peptides for use in immunotherapy again...

Antibody against glypican-3 and application thereof

T cell receptor-deficient t cell compositions

Bacillus Calmette-Guerin (BCG) and antigen presenting cells for tre...

Method of treating cancer using disulfide-linked trimeric OX40L

Tissue factor pathway inhibitor antibodies and uses thereof

Vaccine in combination with an immune checkpoint inhibitor for use...

Anti-MERTK agonistic antibodies and uses thereof

Antibodies and vaccines for use in treating ROR1 cancers and inhibi...

Chimeric antigen receptor specific for tumor cells

Compositions targeting apoptosis-associated speck-like protein with...

Immune tolerant elastin-like peptide tetramer guided nanoparticles...

EPHA2 antibodies

Cancer vaccines targeting BORIS and uses thereof

B*44 restricted peptides for use in immunotherapy against cancers a...

Enhanced antigen presenting ability of RNA car T cells by co-introd...

CaMKK2 inhibitor compositions and methods of using the same

CCR8 peptide and T cells for use in immunotherapeutic treatment of...

Peptides and combination of peptides and scaffolds thereof for use...

Concatemeric peptide epitope RNAs

Chimeric antigen receptors targeting CD70

Cyclic dinucleotide analogue, pharmaceutical composition thereof, a...

Methods and compositions for car T cell therapy

T cell modification and use thereof

Vaccinal strategy

Peptides and combination of peptides for use in immunotherapy again...

Compounds including a mutant KRAS sequence and a lipid and uses the...

Nucleoside-modified RNA for inducing an adaptive immune response

Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...

Patents Applicationslast 30 patents

IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSC...

THERAPEUTIC RNA FOR LUNG CANCER

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAIN...

COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES

METHODS AND COMPOSITIONS FOR TREATING CANCER

EMBRYONIC ANGIOGENESIS MARKERS AND DIAGNOSTIC AND THERAPEUTIC STRAT...

COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER

VERSATILE VIRUS-LIKE-VESICLES (VLV) PLATFORM FOR INFECTIOUS DISEASE...

EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPO...

ENHANCED CELL-DERIVED VESICLES FOR CANCER THERAPY

PHARMACEUTICAL COMPOSITION

TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF

TRIMERIC ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS A...

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

DESIGN OF IMMUNOSTIMULATORY PROTEIN-CORE SPHERICAL NUCLEIC ACIDS

EPITOPE PEPTIDE FOR TUMOR-ASSOCIATED ANTIGEN AND USE THEREOF

VECTOR FOR CANCER TREATMENT

ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS

SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY

TLR AGONISTS FOR REDUCING ACTIVATION-INDUCED PD-1 EXPRESSION ON T C...

VACCINATION IN ELDERLY PATIENTS

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

RNA CONSTRUCTS AND USES THEREOF

TRANSGENIC MOUSE EXPRESSING HUMAN CEREBLON

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

METHOD OF COMPACT PEPTIDE VACCINES USING RESIDUE OPTIMIZATION

POLYMERIC NANOPARTICLE GENETIC VACCINES

NANOPARTICLES FOR ANTIGEN-SPECIFIC CELL PROGRAMMING AND USES THEREOF

PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFEREN...

MULTIPLEXED TP53 AND PAN-RAS mRNA CANCER VACCINES